Novartis Institutes For Biomedical Research GmbH
Novartis Institutes for Biomedical Research GmbH, a key subsidiary of Novartis AG, is headquartered in Austria and operates extensively across Europe and North America. Founded in 1996, the institute has established itself as a leader in the pharmaceutical and biotechnology industry, focusing on innovative drug discovery and development.
Specialising in areas such as oncology, neuroscience, and immunology, Novartis Institutes for Biomedical Research is renowned for its commitment to advancing scientific knowledge and improving patient outcomes. The institute's unique approach combines cutting-edge research with state-of-the-art technology, enabling the development of transformative therapies.
With a strong market position, Novartis Institutes for Biomedical Research has achieved numerous milestones, including breakthroughs in targeted therapies and personalised medicine. Its dedication to innovation and excellence continues to shape the future of healthcare, making it a pivotal player in the global biomedical landscape.
+71 vs industry average
Novartis Institutes For Biomedical Research GmbH’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis Institutes For Biomedical Research GmbH?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Reported emissions
No reported emissions data is available for Novartis Institutes For Biomedical Research GmbH yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis Institutes For Biomedical Research GmbH’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis Institutes For Biomedical Research GmbH yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Novartis Institutes For Biomedical Research GmbH yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project